Cargando…
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients
Autores principales: | Del Zompo, Fabio, De Maio, Flavio, Santopaolo, Francesco, Ricci, Rosalba, Gasbarrini, Antonio, Pompili, Maurizio, Ponziani, Francesca Romana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896814/ https://www.ncbi.nlm.nih.gov/pubmed/33707148 http://dx.doi.org/10.1016/j.dld.2021.02.015 |
Ejemplares similares
-
Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection
por: Ponziani, Francesca Romana, et al.
Publicado: (2021) -
Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients
por: Faccia, Mariella, et al.
Publicado: (2022) -
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection
por: De Maio, Flavio, et al.
Publicado: (2021) -
Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
por: Cerreto, Maria, et al.
Publicado: (2021) -
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
por: Stella, Leonardo, et al.
Publicado: (2022)